Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Body composition and clinical symptoms in patients with hip or knee osteoarthritis: Results from the KHOALA cohort.

Jeanmaire C, Mazières B, Verrouil E, Bernard L, Guillemin F, Rat AC.

Semin Arthritis Rheum. 2018 Jun;47(6):797-804. doi: 10.1016/j.semarthrit.2017.10.012. Epub 2017 Oct 18.

PMID:
29224976
2.

Prevalence of pelvic Paget's disease of bone in France.

Mazières B, Coste J, Euller-Ziegler L, Fardellone P, Fautrel B, Pouchot J, Rat AC, Roux CH, Saraux A, Verrouil E, Guillemin F.

Bone. 2018 Feb;107:143-144. doi: 10.1016/j.bone.2017.11.017. Epub 2017 Nov 22. No abstract available.

PMID:
29175270
3.

Association between hip morphology and prevalence, clinical severity and progression of hip osteoarthritis over 3 years: The knee and hip osteoarthritis long-term assessment cohort results.

Bouyer B, Mazieres B, Guillemin F, Bouttier R, Fautrel B, Morvan J, Pouchot J, Rat AC, Roux CH, Verrouil E, Saraux A, Coste J; KHOALA cohort study group.

Joint Bone Spine. 2016 Jul;83(4):432-8. doi: 10.1016/j.jbspin.2015.09.005. Epub 2016 Jan 29.

PMID:
26832187
4.

Femoro-tibial knee osteoarthritis: One or two X-rays? Results from a population-based study.

Roux CH, Mazieres B, Verrouil E, Rat AC, Fardellone P, Fautrel B, Pouchot J, Saraux A, Guillemin F, Euller-Ziegler L, Coste J.

Joint Bone Spine. 2016 Jan;83(1):37-42. doi: 10.1016/j.jbspin.2015.04.013. Epub 2015 Oct 28.

PMID:
26520886
5.

Relationship between hip dysplasia, pain, and osteoarthritis in a cohort of patients with hip symptoms.

Morvan J, Bouttier R, Mazieres B, Verrouil E, Pouchot J, Rat AC, Guellec D, Guillemin F, Coste J, Saraux A; KHOALA Cohort Study Group.

J Rheumatol. 2013 Sep;40(9):1583-9. doi: 10.3899/jrheum.121544. Epub 2013 Jul 15.

PMID:
23858046
6.

Diffuse idiopathic skeletal hyperostosis (Forestier-Rotes-Querol disease): what's new?

Mazières B.

Joint Bone Spine. 2013 Oct;80(5):466-70. doi: 10.1016/j.jbspin.2013.02.011. Epub 2013 Apr 6. Review.

PMID:
23566663
7.

Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study.

Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, Dougados M, Mazières B, Spector TD, Halhol H, Grouin JM, Lequesne M.

Ann Rheum Dis. 2014 Feb;73(2):376-84. doi: 10.1136/annrheumdis-2012-202485. Epub 2013 Jan 23.

8.

Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology.

Wendling D, Dougados M, Berenbaum F, Brocq O, Schaeverbeke T, Mazieres B, Marcelli C, Leparc JM, Bertin P, Robin M, Sibilia J, Lafforgue P, Prati C, Combe B, Gottenberg JE; French Society of Rheumatology and the Club Rhumatismes et Inflammation.

J Rheumatol. 2012 Dec;39(12):2327-31. doi: 10.3899/jrheum.120201. Epub 2012 Aug 15.

PMID:
22896028
9.

The KHOALA cohort of knee and hip osteoarthritis in France.

Guillemin F, Rat AC, Roux CH, Fautrel B, Mazieres B, Chevalier X, Euller-Ziegler L, Fardellone P, Verrouil E, Morvan J, Pouchot J, Coste J, Saraux A; KHOALA cohort study.

Joint Bone Spine. 2012 Dec;79(6):597-603. doi: 10.1016/j.jbspin.2012.03.011. Epub 2012 Jun 20.

PMID:
22726638
10.

Reproducibility of radiographic hip measurements in adults.

Bouttier R, Morvan J, Mazieres B, Rat AC, Ziegler LE, Fardellone P, Fautrel B, Guillemin F, Pouchot J, Roux C, Coste J, Saraux A.

Joint Bone Spine. 2013 Jan;80(1):52-6. doi: 10.1016/j.jbspin.2012.02.002. Epub 2012 Mar 23.

PMID:
22445554
11.

Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry.

Couderc M, Gottenberg JE, Mariette X, Hachulla E, Sibilia J, Fain O, Hot A, Dougados M, Euller-Ziegler L, Bourgeois P, Larroche C, Tournadre A, Amoura Z, Mazières B, Arlet P, De Bandt M, Schaeverbeke T, Soubrier M.

Rheumatology (Oxford). 2011 Dec;50(12):2283-9. doi: 10.1093/rheumatology/ker305. Epub 2011 Oct 22.

PMID:
22019807
12.

Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey.

Guillemin F, Rat AC, Mazieres B, Pouchot J, Fautrel B, Euller-Ziegler L, Fardellone P, Morvan J, Roux CH, Verrouil E, Saraux A, Coste J; 3000 Osteoarthritis group.

Osteoarthritis Cartilage. 2011 Nov;19(11):1314-22. doi: 10.1016/j.joca.2011.08.004. Epub 2011 Aug 16.

13.

Multifocal bone infarcts and buprenorphine: association or coincidence?

Laroche M, Brouchet A, Mazières B.

J Rheumatol. 2009 Oct;36(10):2369-70. doi: 10.3899/jrheum.090100. No abstract available.

PMID:
19820227
14.

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.

Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, Herrero-Beaumont G, Kirschner S, Leeb BF, Lohmander LS, Mazières B, Pavelka K, Punzi L, So AK, Tuncer T, Watt I, Bijlsma JW.

Ann Rheum Dis. 2010 Mar;69(3):483-9. doi: 10.1136/ard.2009.113100. Epub 2009 Sep 17. Review.

PMID:
19762361
15.

Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial.

Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazières B, Maugars Y, Mulleman D, Clerson P, Chevalier X.

Arthritis Rheum. 2009 Mar;60(3):824-30. doi: 10.1002/art.24301.

16.

Self-reported prevalence of psoriasis and evaluation of the impact on the natural history of hip osteoarthritis: results of a 10 years follow-up study of 507 patients (ECHODIAH study).

Kalyoncu U, Gossec L, Nguyen M, Berdah L, Mazières B, Lequesne M, Dougados M.

Joint Bone Spine. 2009 Jul;76(4):389-93. doi: 10.1016/j.jbspin.2008.10.007. Epub 2009 Feb 12.

PMID:
19217337
17.

A case-control study to assess sensitivity and specificity of a questionnaire for the detection of hip and knee osteoarthritis.

Morvan J, Roux CH, Fautrel B, Rat AC, Euller-Ziegler L, Loeuille D, Banal F, Mazieres B, Coste J, Saraux A, Guillemin F.

Arthritis Rheum. 2009 Jan 15;61(1):92-9. doi: 10.1002/art.24079.

18.

Adherence to, and results of, physical therapy programs in patients with hip or knee osteoarthritis. Development of French clinical practice guidelines.

Mazières B, Thevenon A, Coudeyre E, Chevalier X, Revel M, Rannou F.

Joint Bone Spine. 2008 Oct;75(5):589-96. doi: 10.1016/j.jbspin.2008.02.016. Epub 2008 Sep 19.

PMID:
18805033
19.

Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates.

Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, Testa J, Fardellone P, Rat AC, Coste J, Guillemin F, Euller-Ziegler L; KHOALA Osteoarthritis Group.

Ann Rheum Dis. 2008 Oct;67(10):1406-11. Epub 2007 Dec 12.

PMID:
18077540
20.

Medicoeconomic evaluation of hyaluronic acid for knee osteoarthritis in everyday practice: the MESSAGE study.

Mazières B, Bard H, Ligier M, Bru I, d'Orsay GG, Le Pen C.

Joint Bone Spine. 2007 Oct;74(5):453-60. Epub 2007 Aug 9.

PMID:
17921022
21.

Distal renal tubular acidosis and ovalocytosis: a case report.

Jamard B, Allard J, Caron P, Corberand JX, Blanchard A, Vargas-Poussou R, El Mahou S, Constantin A, Cantagrel A, Mazières B, Laroche M.

Osteoporos Int. 2008 Jan;19(1):119-22. Epub 2007 Aug 10.

PMID:
17690931
22.

Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes.

Boyer JF, Balard P, Authier H, Faucon B, Bernad J, Mazières B, Davignon JL, Cantagrel A, Pipy B, Constantin A.

Arthritis Res Ther. 2007;9(2):R22.

23.

A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis.

Gourraud PA, Dieudé P, Boyer JF, Nogueira L, Cambon-Thomsen A, Mazières B, Cornélis F, Serre G, Cantagrel A, Constantin A.

Arthritis Res Ther. 2007;9(2):R27.

24.

Chondroitin sulfate in the management of hip and knee osteoarthritis: an overview.

Bana G, Jamard B, Verrouil E, Mazières B.

Adv Pharmacol. 2006;53:507-22. Review. No abstract available.

PMID:
17239784
25.

Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.

Mazières B, Hucher M, Zaïm M, Garnero P.

Ann Rheum Dis. 2007 May;66(5):639-45. Epub 2007 Jan 4.

26.
27.

Systemic vasculitis revealing a benign tumor: a paraneoplastic syndrome?

Plaut MA, El Mahou S, Popa L, Cantagrel A, Mazières B, Laroche M.

Joint Bone Spine. 2006 Jul;73(4):462-4. Epub 2006 Mar 20.

PMID:
16807043
28.

[Atypical crowned dens syndrome].

El Mahou S, Popa L, Jamard B, Constantin A, Cantagrel A, Mazieres B, Laroche M.

Presse Med. 2006 May;35(5 Pt 1):803-4. French. No abstract available.

PMID:
16710152
29.

Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation.

El Mahou S, Popa L, Constantin A, Cantagrel A, Aberrane A, Jamard B, Mazieres B, Laroche M.

Clin Rheumatol. 2006 Jul;25(4):566-7. Epub 2006 Mar 25.

PMID:
16565898
30.

Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study.

Laroche M, Cantogrel S, Jamard B, Constantin A, Zabraniecki L, Cantagrel A, Mazières B.

Clin Rheumatol. 2006 Sep;25(5):683-6. Epub 2006 Jan 4.

PMID:
16391891
31.

Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?

El Mahou S, Attal M, Jamard B, Constantin A, Cantagrel A, Mazières B, Arnaud C, Laroche M.

Clin Rheumatol. 2006 Mar;25(2):175-82. Epub 2005 Nov 23.

PMID:
16328086
32.

Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.

Mazières B, Garnero P, Guéguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M.

Ann Rheum Dis. 2006 Mar;65(3):354-9. Epub 2005 Dec 1.

33.

Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval.

Maheu E, Cadet C, Marty M, Dougados M, Ghabri S, Kerloch I, Mazières B, Spector TD, Vignon E, Lequesne MG.

Arthritis Res Ther. 2005;7(6):R1375-85. Epub 2005 Oct 5.

34.

Topical ketoprofen patch.

Mazières B.

Drugs R D. 2005;6(6):337-44. Review.

PMID:
16274258
35.

Multiple intraosseous meningiomas.

El Mahou S, Popa L, Constantin A, Jamard B, Cantagrel A, Mazieres B, Laroche M.

Clin Rheumatol. 2006 Jul;25(4):553-4. Epub 2005 Nov 5.

PMID:
16273308
36.

Topical ketoprofen patch in the treatment of tendinitis: a randomized, double blind, placebo controlled study.

Mazières B, Rouanet S, Guillon Y, Scarsi C, Reiner V.

J Rheumatol. 2005 Aug;32(8):1563-70.

PMID:
16078335
37.

New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist.

Boyer JF, Jamard B, El Mahou S, Laroche M, Mazières B, Cantagrel A, Constantin A.

Clin Exp Rheumatol. 2005 Mar-Apr;23(2):274-5. No abstract available.

PMID:
15895906
38.

Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort.

Garnero P, Mazières B, Guéguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M.

J Rheumatol. 2005 Apr;32(4):697-703.

PMID:
15801028
39.

Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study.

Mazières B, Rouanet S, Velicy J, Scarsi C, Reiner V.

Am J Sports Med. 2005 Apr;33(4):515-23. Epub 2005 Feb 8.

PMID:
15722295
40.

Level of acceptability of EULAR recommendations for the management of knee osteoarthritis by practitioners in different European countries.

Mazières B, Scmidely N, Hauselmann HJ, Martin-Mola E, Serni U, Verbruggen AA, Le Bars M.

Ann Rheum Dis. 2005 Aug;64(8):1158-64. Epub 2005 Feb 11.

41.
42.

Epithelioid haemangioendothelioma and paraneoplastic hypercorticism.

El Mahou S, Jamard B, Constantin A, Cantagrel A, Mazieres B, Laroche M.

Rheumatology (Oxford). 2004 Nov;43(11):1458-9. No abstract available.

PMID:
15502004
43.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M; EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Ann Rheum Dis. 2005 May;64(5):669-81. Epub 2004 Oct 7. Review.

44.

Severe refractory hypocalcemia in patients with enteropathy: consider hypomagnesemia.

Roitg I, Jamard B, Constantin A, Cantagrel A, Mazières B, Laroche M.

Joint Bone Spine. 2004 May;71(3):252-3. No abstract available.

PMID:
15182803
45.

Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis.

Constantin A, Dieudé P, Lauwers-Cancès V, Jamard B, Mazières B, Cambon-Thomsen A, Cornélis F, Cantagrel A.

Arthritis Rheum. 2004 Mar;50(3):742-7.

46.

The therapeutic approach to osteoarthritis.

Mazières B, Jamard B, Verrouil E, Constantin A, Laroche M, Cantagrel A.

Aging Clin Exp Res. 2003 Oct;15(5):405-12. Review.

PMID:
14703006
47.

[Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service].

Cabou C, Bagheri H, Cantagrel A, Mazières B, Montastruc JL.

Therapie. 2003 Sep-Oct;58(5):457-62. Review. French.

PMID:
14682196
48.

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT.

Ann Rheum Dis. 2003 Dec;62(12):1145-55. Review.

49.

Sex differences in hip osteoarthritis: results of a longitudinal study in 508 patients.

Maillefert JF, Gueguen A, Monreal M, Nguyen M, Berdah L, Lequesne M, Mazieres B, Vignon E, Dougados M.

Ann Rheum Dis. 2003 Oct;62(10):931-4.

50.

Osteomalacia and sacroiliitis.

El Mahou S, Moineuse C, Navaux F, Cantagrel A, Mazieres B, Laroche M.

Joint Bone Spine. 2003 Aug;70(4):310-2. No abstract available.

PMID:
12951319

Supplemental Content

Loading ...
Support Center